Tigeryeah Capital
Tigeryeah Capital is a venture capital firm.
Business Model:
Revenue: $0
Employees: 0-0
Rankings
Industries / Tags:
Detailed Tigeryeah Capital Information
Geographic Data
Address: Dongguan Building, No. 618 Jiangnan Road
City: Hangzhou
State: zhejiang province
Zip: 310053
Country: CN
Financial Info
Stage:
Raised Last:
$0
Raised Total:$0
Social
Crunchbase
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Founded in 2014, TigerYeah Capital team has in-depth experiences in investment management and professional healthcare background. TigerYeah is dedicated to build itself as a famous brand in healthcare investment field and become the top tier investment firm. Relying on their superior professional management team, TigerYeah will enable both clients and invested portfolio enterprises to gain the success. TigerYeah focuses on early and growing equity investment in healthcare, especially in the field of the Medical Device, Health Food, CRO and Health Services. By leveraging Tigermed solid platform and TigerYeah abundant industrial knowhow and resources, TigerYeah provides comprehensive post-investment services for entrepreneurs to accelerate the products&s; launch into market,speed up business development process, strengthen and upgrade the integration of the relevant industrial resources. TigerYeah is willing to contribute greater value as well as grow together with the enterprises.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 5/2017 | Yaxincheng | Angel Round | 434.3k |
| 1/2022 | Enze Kangtai | Series A | - |
| 3/2017 | Hanyu Medical | Angel Round | - |
| 3/2021 | Novamab | Series A | 15.4M |
| 12/2021 | Hesguard | Seed Round | 15.7M |
| 1/2021 | MagAssist | Series B | 0 |
| 12/2020 | Insight Lifetech | Series C | 27.6M |
| 3/2022 | Tingsheng Technology | Series A | 15.8M |
| 8/2022 | Epigenic Therapeutics | Seed Round | 0 |
| 4/2018 | Hanyu Medical | Venture Round | - |
| 9/2017 | MED.CIRCLE | Angel Round | 450.8k |
| 4/2020 | Precogify | Seed Round | 2.8M |
| 5/2021 | Hangzhou DAC Biotech Co., Ltd | Series C | 154.9M |
| 8/2022 | Epigenic Therapeutics | Seed Round | 0 |
| 3/2022 | Tingsheng Technology | Series A | 0 |
| 1/2022 | Enze Kangtai | Series A | - |
| 12/2021 | Hesguard | Seed Round | 0 |
| 5/2021 | Hangzhou DAC Biotech Co., Ltd | Series C | 0 |
| 3/2021 | Novamab | Series A | 0 |
| 1/2021 | MagAssist | Series B | 0 |
| 12/2020 | Insight Lifetech | Series C | 0 |
| 4/2020 | Precogify | Seed Round | 0 |
| 4/2018 | Hanyu Medical | Venture Round | - |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
